Novel non-peptide inhibitors targeting death receptor-mediated apoptosis

Bioorg Med Chem Lett. 2003 Nov 3;13(21):3743-6. doi: 10.1016/j.bmcl.2003.08.003.

Abstract

We have previously reported that ECH, (2R, 3R, 4S)-2,3-epoxy-4-hydroxy-5-hydroxymethyl-6-(1E)-propenyl-cyclohex-5-en-1-one inhibits Fas-mediated apoptosis by blocking self-activation of pro-caspase-8 in the death-inducing signaling complex (DISC). A series of ECH derivatives were asymmetrically synthesized via key synthetic intermediates obtained from lipase-catalyzed kinetic resolution. Inhibitory activities of the derivatives towards death receptor-mediated apoptosis both in type I and type II cells were investigated, revealing that novel non-peptide inhibitors, RKTS-33 and RKTS-34, are effective as ECH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Cell Line
  • Fas Ligand Protein
  • Humans
  • Indicators and Reagents
  • Jurkat Cells
  • Kinetics
  • Lipase / metabolism
  • Magnetic Resonance Spectroscopy
  • Membrane Glycoproteins / antagonists & inhibitors
  • Structure-Activity Relationship
  • fas Receptor / drug effects

Substances

  • FASLG protein, human
  • Fas Ligand Protein
  • Indicators and Reagents
  • Membrane Glycoproteins
  • fas Receptor
  • Lipase